EUCTR2008-000714-74-SE
Active, not recruiting
Not Applicable
Premedication in paediatric patients: Dose finding study of clonidine administrated as nasal aerosol.
Institution of Paediatric Anaesthesia and intensiv care, Astrid Lindgren Childrens Hospital, Karolin0 sitesFebruary 14, 2008
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Institution of Paediatric Anaesthesia and intensiv care, Astrid Lindgren Childrens Hospital, Karolin
- Status
- Active, not recruiting
- Last Updated
- 14 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.ASA class I and II patients
- •2\.Patients between the age of 6 months and 6 years with a weight between 10 and 25 kilogram.
- •3\.Planned for a surgical procedure at Astrid Lindgrens Childrens Hospital which require generell anaesthesia
- •4\.Oral and written consent from the patient/parent
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) no
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •1\.Known allergy to clonidine
- •2\.Impaired development/mental handicap which makes grading of sedation impossible
- •3\.Language diffuculties requiring information by interpreter
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Traitement précoce de patients pédiatriques présentant un syndrome hémolytique et urémique typique par l’anticorps monoclonal anti-C5 eculizumab : essai thérapeutique prospectif randomisé contrôlé contre placebo de phase IIIHemolytic and uremic syndromeMedDRA version: 17.0 Level: LLT Classification code 10042814 Term: Syndrome hemolytic uremic System Organ Class: 100000004851Therapeutic area: Diseases [C] - Symptoms and general pathology [C23]EUCTR2014-001169-28-FRCentre Hospitalier de Toulouse100
Active, not recruiting
Phase 1
Preanesthetic medication in pediatric patients: A comparison of midazolam, clonidine and dexmedetomidineIs there a difference in anxiety- and sedation-level, and in anesthesia induction compliance between the preanesthetics included in study, in pediatric patients? Can we prevent and reduce anxiety without causing negative cardiorespiratory effects by selected preanesthetic included in study, in TIVA in pediatric patients? Does the preanesthetic used in this study prevent and/or reduce pain, vomiting, shivering, events of emergence delirium and maladaptive behaviors, without prolonging recovery?Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]EUCTR2015-003676-70-SEorrbottens läns landsting
Active, not recruiting
Phase 1
A PAEDIATRIC PHASE I/II STUDY OF INTERMITTENT DOSING OF THE MEK-1 INHIBITOR SELUMETINIB IN CHILDREN WITH NEUROFIBROMATOSIS TYPE-1 AND INOPERABLE PLEXIFORM NEUROFIBROMA AND/OR PROGRESSIVE OPTIC PATHWAY GLIOMANeurofibromatosis type 1 associated plexiform neurofibromas Neurofibromatosis type 1 associated progressive or relapsed optic pathway gliomaMedDRA version: 20.0 Level: LLT Classification code 10029270 Term: Neurofibromatosis, type 1 (von Recklinghausen's disease) System Organ Class: 100000004850MedDRA version: 20.0 Level: LLT Classification code 10065866 Term: Plexiform neurofibroma System Organ Class: 100000004864MedDRA version: 20.0 Level: LLT Classification code 10030935 Term: Optic nerve glioma System Organ Class: 100000004864Therapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2017-002635-41-GBGreat Ormond Street Hospital38
Completed
Not Applicable
Prediction of medication response in children with ADHD: EEG differences between responders and non-responders to methylphenidate.ADHD, methylphenidate response, EEG, DNA, CANTAB, spatial span, spatial working memory, stop-task, CPT, theta/beta ratioNL-OMON26488trecht Institute for Pharmaceutical Sciences, Utrecht University50
Completed
Not Applicable
Prediction of medication response in children with Attention Deficit Hyperactivity Disorder (ADHD): Electroencephalogram (EEG) differences between responders and non-responders to methylphenidateMedication response in children with Attention Deficit Hyperactivity Disorder (ADHD)Mental and Behavioural DisordersHyperkinetic disordersISRCTN32841168trecht Institute for Pharmaceutical Sciences (The Netherlands)50